These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 25499970

  • 21. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
    Han M, Gao H, Ju P, Gao MQ, Yuan YP, Chen XH, Liu KL, Han YT, Han ZW.
    Biomed Pharmacother; 2018 Jul; 103():272-283. PubMed ID: 29656183
    [Abstract] [Full Text] [Related]

  • 22. Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis.
    Sun W, Shen ZY, Zhang H, Fan YZ, Zhang WZ, Zhang JT, Lu XS, Ye C.
    Oncol Rep; 2012 Jun; 27(6):1990-2002. PubMed ID: 22470047
    [Abstract] [Full Text] [Related]

  • 23. Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo.
    Wang W, Hu Z, Huang Y, Zheng H, Sun Q, Yang Q, Zhang Y, Zhang L, Wang W.
    Biomed Res Int; 2019 Jun; 2019():9205851. PubMed ID: 31019975
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
    Takada N, Sugano H, Shirai Y, Saito N, Hamura R, Taniai T, Uwagawa T, Yanaga K, Ikegami T, Ohashi T, Eto K.
    PLoS One; 2021 Jun; 16(9):e0257019. PubMed ID: 34473771
    [Abstract] [Full Text] [Related]

  • 26. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
    Ma J, Zi Jiang Y, Shi H, Mi C, Li J, Xing Nan J, Wu X, Joon Lee J, Jin X.
    Eur J Pharmacol; 2014 Jan 15; 723():46-54. PubMed ID: 24333213
    [Abstract] [Full Text] [Related]

  • 27. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
    Zhang GF, Wu JC, Wang HY, Jiang WD, Qiu L.
    Biosci Rep; 2020 Sep 30; 40(9):. PubMed ID: 32869841
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
    Wang FT, Wang H, Wang QW, Pan MS, Li XP, Sun W, Fan YZ.
    Cancer Chemother Pharmacol; 2020 Aug 30; 86(2):221-232. PubMed ID: 32654071
    [Abstract] [Full Text] [Related]

  • 29. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
    Shen Y, Bian R, Li Y, Gao Y, Liu Y, Xu Y, Song X, Zhang Y.
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun 20; 51(6):607-614. PubMed ID: 31074773
    [Abstract] [Full Text] [Related]

  • 30. Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-κB signaling pathway leads to the formation of a loop between HIF-1α and MUC1-C promoting chemoresistance in bladder cancer.
    Qing L, Li Q, Yang Y, Xu W, Wang Y, Li R, You C, Dong Z.
    Mol Carcinog; 2024 Jul 20; 63(7):1303-1318. PubMed ID: 38634741
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ganoderic acid D attenuates gemcitabine resistance of triple-negative breast cancer cells by inhibiting glycolysis via HIF-1α destabilization.
    Luo B, Song L, Chen L, Cai Y, Zhang M, Wang S.
    Phytomedicine; 2024 Jul 20; 129():155675. PubMed ID: 38678954
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
    Yin W, Xu J, Li C, Dai X, Wu T, Wen J.
    Cell Biol Int; 2020 Aug 20; 44(8):1616-1627. PubMed ID: 32239594
    [Abstract] [Full Text] [Related]

  • 37. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
    Zhang X, Qi Z, Yin H, Yang G.
    Theranostics; 2019 Aug 20; 9(4):1096-1114. PubMed ID: 30867818
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.
    Zhao T, Ren H, Jia L, Chen J, Xin W, Yan F, Li J, Wang X, Gao S, Qian D, Huang C, Hao J.
    Oncotarget; 2015 Feb 10; 6(4):2250-62. PubMed ID: 25544770
    [Abstract] [Full Text] [Related]

  • 39. Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated downregulation of PTX3.
    Ahmmed B, Kampo S, Khan M, Faqeer A, Kumar SP, Yulin L, Liu JW, Yan Q.
    J Cell Physiol; 2019 Jul 10; 234(7):10680-10697. PubMed ID: 30628067
    [Abstract] [Full Text] [Related]

  • 40. IL-37 suppresses migration and invasion of gallbladder cancer cells through inhibition of HIF-1α induced epithelial-mesenchymal transition.
    Wu TJ, Xu B, Zhao GH, Luo J, Luo C.
    Eur Rev Med Pharmacol Sci; 2018 Dec 10; 22(23):8179-8185. PubMed ID: 30556856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.